GlaxoSmithKline’s quest for improved anti-malarial treatments has been revolutionized by the speed and reliability of the HP D300 Digital Dispenser.
(PressReleasePoint) - GlaxoSmithKline’s quest for improved anti-malarial treatments has been revolutionized by the speed and reliability of the HP D300 Digital Dispenser. The system – distributed by Tecan – has enabled scientists working at GSK’s Malaria Discovery Performance Unit (DPU) in Tres Cantos, Spain, to increase throughput for standard drug titrations and to test additional combinations of candidate compounds. Dr Laura Sanz, an investigator in the Malaria DPU’s Biochemistry and Parasitology Department, explained: “We have been working with the HP D300 since autumn 2012, and it has significantly increased our sample throughput. Plates can be prepared more rapidly and, consequently, compound evaluation can be initiated earlier. This allows new experiments to be started sooner, increasing the rate at which a project progresses. It also saves a great deal of hands-on time and frees staff to undertake other laboratory activities.”
“Our quality standards are extremely high, and our priorities are speed and reliability. The HP D300 has exceeded our expectations, helping us to find faster ways of achieving our goals and allowing us to do everything we want to do. It’s a user-friendly instrument that fits perfectly into our laboratory’s lead optimization operations, enabling us to test combinations of compounds more easily and providing a great opportunity to carry out investigations that were previously difficult to perform,” concluded Laura.
To find out more about Tecan’s HP D300 Digital Dispenser, visit www.tecan.com/digitaltitration
For more information please contact
Tecan Trading AG
Cornelia Kegele / Antonietta Allocca
Seestrasse 103, CH-8708 Männedorf
Tel +41 (0)44 922 81 11, Fax +41 (0)44 922 81 12
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2013, Tecan generated sales of CHF 388 million (USD 419 million; EUR 316 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).